SANDOZ MOMETASONE

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 49a703cd6315c3ca
Drug Approval Canada Name: SANDOZ MOMETASONE
Product Name: SANDOZ MOMETASONE
Status: Marketed
Status Date: 2016-07-27
Original Market Date: 2016-07-27
Din: 02449811
Drug Class: Human
Dosage Form: Spray, Metered Dose
Route Of Administration: Nasal
Schedule: Prescription
Ahfs: 52:08.08
Atc Original: R01AD09 MOMETASONE
Atc Name: r 01 ad 09
Aig Number: 0121732002
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

MOMETASONE FUROATE (MOMETASONE FUROATE MONOHYDRATE)

50 MCG / ACT

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

49a703cd6315c3ca

Type

Standard